Skip to Content
Request Appointment
Clinical Trials
Patient Portal
Cancer Care
Providers
Locations
About
Request Appointment
Loading component...
TOP
A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 when Used in Combination with Ramucirumab and Paclitaxel in Patients with Gastric Cancer
Phase
Phase II Clinical Trial
Trial Number
06038578
Trial Status
OPEN
Study Overview
Learn More About This Study
Participating Locations
